(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 4972.00 | 5590.70 | 4318.55 | -11.1% | 15.1% |
Total Expenses | 4612.40 | 5059.80 | 4068.52 | -8.8% | 13.4% |
Profit Before Tax | 359.60 | 530.90 | 250.03 | -32.3% | 43.8% |
Tax | 109.80 | 156.80 | 107.96 | -30.0% | 1.7% |
Profit After Tax | 258.40 | 379.40 | 145.64 | -31.9% | 77.4% |
Earnings Per Share | 17.60 | 25.90 | 10.10 | -32.0% | 74.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Apollo Hospitals Enterprise Ltd is a leading healthcare provider in India, known for its comprehensive range of healthcare services. The company operates hospitals and clinics, offering services that include primary, secondary, and tertiary care, as well as health insurance and pharmacy services. Apollo Hospitals is regarded as a pioneer in the Indian healthcare industry, with a reputation for high-quality medical care and advanced healthcare technology. It has a significant presence across the country, with a network of hospitals, clinics, and pharmacies. The company's focus is on delivering superior clinical outcomes and patient satisfaction through state-of-the-art facilities and expert medical professionals.
In the fourth quarter of fiscal year 2025 (Q4FY25), Apollo Hospitals reported a total income of ₹4972.00 crores. This represents a decrease of 11.1% compared to the previous quarter (Q3FY25), where the total income was ₹5590.70 crores. However, when compared year-over-year (YoY) with the same quarter in the previous year (Q4FY24), the company saw an increase of 15.1% from ₹4318.55 crores. These figures indicate a positive YoY growth in revenues, despite the quarter-over-quarter (QoQ) decline. The revenue trends reflect the company's performance within the period, showing resilience in annual growth despite a recent quarterly dip.
Apollo Hospitals' profitability metrics for Q4FY25 illustrate varied performance trends. The company recorded a Profit Before Tax (PBT) of ₹359.60 crores, which is a 32.3% decrease from the previous quarter's PBT of ₹530.90 crores. However, this is a significant improvement of 43.8% from the PBT of ₹250.03 crores in Q4FY24. The Profit After Tax (PAT) for Q4FY25 was ₹258.40 crores, down by 31.9% from Q3FY25, but up by an impressive 77.4% from Q4FY24's PAT of ₹145.64 crores. These figures show strong YoY improvement despite a decline from the prior quarter. This trend is also reflected in the Earnings Per Share (EPS), which decreased to ₹17.60 from ₹25.90 in Q3FY25, but increased significantly from ₹10.10 in Q4FY24, showing a YoY rise of 74.3%.
The total expenses for Apollo Hospitals in Q4FY25 were ₹4612.40 crores, marking an 8.8% decrease from the previous quarter's expenses of ₹5059.80 crores. On a YoY basis, this represents a 13.4% increase from ₹4068.52 crores in Q4FY24. The tax expenses for Q4FY25 were ₹109.80 crores, which decreased by 30.0% from Q3FY25's tax of ₹156.80 crores. Compared to Q4FY24, the tax expenses showed a marginal increase of 1.7% from ₹107.96 crores. These operating metrics highlight the company's cost management and tax obligations over the periods, reflecting changes in operational efficiency and tax strategy between the quarters and the fiscal years.